Biotecnología
Biotecnología
Andelyn Biosciences to Bring First Gene Therapy for Treatment of INAD to Clinical Trials
30/11/2022 -
Infantile Neuroaxonal Dystrophy (INAD) is a rare inherited neurological disorder.
FDA CBER OTAT Patient-Focused Drug Development Listening Meeting — Patient Perspectives on Gene Therapy Products - 11/15/2022
30/11/2022 -
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual patient-focused drug development listening meeting to better...
OTAT Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls - 09/29/2022
23/11/2022 -
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to gene therapy...
Roster of the Cellular, Tissue and Gene Therapies Advisory Committee
23/11/2022 -
This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.
Thermo Fisher Scientific Introduces Gibco CTS AAV-MAX Helper-Free AAV Production System
17/11/2022 -
Helps meet clinical and commercial demands for cost-effective and scalable development of adeno-associated virus-based gene therapies.
Tissue & Advanced Therapies Research
16/11/2022 -
This page is about Tissue & Advanced Therapies Research
Charles River Expands Cell Therapy CDMO Facility in Memphis
15/11/2022 -
Builds on the site’s expertise and commitment to supporting cell and gene therapy clients.
ABL, RD-Biotech Sign Strategic Partnership in Cell and Gene Therapy GMP Mfg.
26/10/2022 -
This collaboration combines the strengths of both companies to offer a new and flexible end-to-end service to C> developers.
Lilly to Acquire Akouos for $487M
19/10/2022 -
Gains lead product candidate, AK-OTOF, a gene therapy for the treatment of hearing loss.
Charles River, Nanoscope Therapeutics Enter Gene Therapy Manufacturing Pact
19/10/2022 -
Collaboration is focused on restoring vision for people suffering from retinal degenerative diseases with no known cure.
Yapan Bio Adds New Process Development Facility
19/10/2022 -
Expands capacity and capabilities in large molecule therapeutics to support development and manufacturing of RNA, DNA and gene therapy products.
Gamma Biosciences, Lonza Enter Cell and Gene Therapy Alliance
17/10/2022 -
BioMagnetic Solutions will supply research and cGMP manufacturing grade FerroSelect reagents to Lonza for use in developing CAR-T and other immunotherapeutics.
“El estudio del microbioma ayudará a diseñar terapias para las enfermedades neurodegenerativas”
13/10/2022 -
Doctora en Biotecnología por la Universidad Autónoma de Barcelona, donde ejerce como investigadora Ramón y Cajal, Natalia Sánchez de Groot (Barcelona, 1981) estudia la relación que existe...
Two Cell and Gene Therapies Manufactured at Lonza Houston Reach FDA Approval
12/10/2022 -
Approvals of Zynteglo and Skysona mean that Lonza’s Houston site now supports three commercial CGT products.
Cytiva Acquires CEVEC Pharmaceuticals
12/10/2022 -
Strengthens viral vector manufacturing and cell line development technologies for gene therapies.
Myrtelle and Forge Biologics Form Manufacturing Partnership
12/10/2022 -
To advance Myrtelle’s novel gene therapy for monogenic hearing loss for Phase 1/2 clinical trials.
NGen Invests $10.5M to Support Commercial Scale Manufacturing of Cell & Gene Therapies in Canada
28/09/2022 -
Project aims to secure Canada’s global leadership in life sciences.
Charles River, Cure AP-4 Enter Manufacturing Pact for Gene Therapy
13/09/2022 -
Charles River will provide High Quality (HQ) plasmid DNA for Cure AP-4’s Phase I/II gene therapy trials against AP-4 HSP.
Cryoport Enters Strategic Relationship with BioLife Plasma Services
13/09/2022 -
The companies aim to establish a standardized, integrated apheresis collection, processing, and distribution solution for cellular therapies.
Catalent Names Dr. Wai Lam Ling as VP, Scientific Advisory
13/09/2022 -
Brings more than 25 years of experience in R&D and CMC operations across biologics and gene therapies.
Applied StemCell Expands Cell and Gene Therapy Manufacturing Facility
01/09/2022 -
To build four additional cGMP cleanrooms, cryo-storage space, and a process development and QC/QA space.
